CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carmella, S. G.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carmella, S. G.
Right arrow Articles by Hecht, S. S.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 1257-1261, November 2003
© 2003 American Association for Cancer Research


Short Communications

Analysis of Total 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in Human Urine

Steven G. Carmella, Shaomei Han, Anne Fristad, Yiying Yang and Stephen S. Hecht

University of Minnesota Cancer Center, Minneapolis, Minnesota

A new method was developed for the analysis of metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human urine. The metabolites are 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-O-Gluc and NNAL-N-Gluc). The sum of these metabolites, total NNAL, was measured with this method. Urine was treated with ß-glucuronidase, which converts NNAL-O-Gluc and NNAL-N-Gluc to NNAL. After solvent partitioning and further purification on a liquid-liquid extraction cartridge and by high-performance liquid chromatography, total NNAL was quantified by gas chromatography with nitrosamine selective detection. The new method is accurate and precise, and the results are in good agreement with those obtained using the traditional method, which quantifies NNAL and its glucuronides separately. Levels of total NNAL ± SD (pmol/mg creatinine) were 2.60 ± 1.30 (n = 41) in smokers, 3.25 ± 1.77 (n = 55) in snuff-dippers, and 0.042 ± 0.020 (n = 18) in nonsmokers exposed to environmental tobacco smoke. The new method is faster and more sensitive than the traditional method and should greatly facilitate studies on human uptake of NNK.




This article has been cited by other articles:


Home page
Tobacco ControlHome page
S S Hecht, S G Carmella, A Edmonds, S E Murphy, I Stepanov, X Luo, and D K Hatsukami
Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco
Tob. Control, April 1, 2008; 17(2): 128 - 131.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, I. Stepanov, J. Jensen, A. Anderson, and D. K. Hatsukami
Metabolism of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone to Its Biomarker Total NNAL in Smokeless Tobacco Users
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 732 - 735.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, S. E. Murphy, W. T. Riley, C. Le, X. Luo, M. Mooney, and D. K. Hatsukami
Similar Exposure to a Tobacco-Specific Carcinogen in Smokeless Tobacco Users and Cigarette Smokers
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1567 - 1572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
M. J. Stark, K. Rohde, J. E. Maher, B. A. Pizacani, C. W. Dent, R. Bard, S. G. Carmella, A. R. Benoit, N. M. Thomson, and S. S. Hecht
The Impact of Clean Indoor Air Exemptions and Preemption Policies on the Prevalence of a Tobacco-Specific Lung Carcinogen Among Nonsmoking Bar and Restaurant Workers
Am J Public Health, August 1, 2007; 97(8): 1457 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, K.-A. Le, S. E. Murphy, A. J. Boettcher, C. Le, J. Koopmeiners, L. An, and D. J. Hennrikus
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 988 - 992.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. E. Tulunay, S. S. Hecht, S. G. Carmella, Y. Zhang, C. Lemmonds, S. Murphy, and D. K. Hatsukami
Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1283 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. Stepanov and S. S. Hecht
Tobacco-Specific Nitrosamines and Their Pyridine-N-glucuronides in the Urine of Smokers and Smokeless Tobacco Users
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 885 - 891.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. K. Hatsukami, C. Lemmonds, Y. Zhang, S. E. Murphy, C. Le, S. G. Carmella, and S. S. Hecht
Evaluation of Carcinogen Exposure in People Who Used "Reduced Exposure" Tobacco Products
J Natl Cancer Inst, June 2, 2004; 96(11): 844 - 852.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.